[HTML][HTML] When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments

V Unfer, E Kandaraki, L Pkhaladze, S Roseff… - … and Metabolic Science, 2024 - Elsevier
Abstract Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that affects a
large proportion of women. Due to its heterogeneity, the best diagnostic strategy has been a …

[HTML][HTML] D-chiro-inositol in clinical practice: A perspective from The Experts Group on Inositol in Basic and Clinical Research (EGOI)

S Dinicola, V Unfer, CO Soulage… - Gynecologic and …, 2024 - karger.com
Background: d-Chiro-inositol is a natural molecule that, in association with its well-studied
isomer myo-inositol, may play a role in treating various metabolic and gynecological …

[HTML][HTML] The cardiometabolic risk in women with polycystic ovarian syndrome (PCOS): From pathophysiology to diagnosis and treatment

S Pililis, S Lampsas, A Kountouri, L Pliouta, E Korakas… - Medicina, 2024 - mdpi.com
Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine disorder affecting women of
reproductive age, with significant variations in presentation characterized by …

Efficacy and safety of dietary polyphenol administration as assessed by hormonal, glycolipid metabolism, inflammation and oxidative stress parameters in patients with …

X Jian, C Shi, T Xu, B Liu, L Zhou… - Critical Reviews in …, 2024 - Taylor & Francis
Background The current knowledge about the efficacy and safety of dietary polyphenol
administration in patients with polycystic ovarian syndrome (PCOS) is divergent. Objective …

[HTML][HTML] Myo-inositol and D-chiro-inositol reduce DHT-stimulated changes in the steroidogenic activity of adult granulosa cell tumors

AM Wojciechowska, P Zając, J Gogola-Mruk… - International Journal of …, 2024 - mdpi.com
Considering the properties of myo-inositol (MI) and D-chiro-inositol (DCI), which are well
known in polycystic ovary syndrome therapy, and the limitations of adult granulosa cell …

Delphi consensus on the diagnostic criteria of polycystic ovary syndrome

F Facchinetti, A Gambineri, G Aimaretti, A Ferlin… - Journal of …, 2025 - Springer
Purpose To gather the current opinion among Italian gynecologists and endocrinologists
regarding the definition, diagnosis, and treatment of polycystic ovary syndrome (PCOS) …

Treatment With a Patented 3.6: 1 Myo-Inositol to D-chiro-Inositol Ratio, Antioxidants, Vitamins and Minerals Food Supplement in Women With a History of Assisted …

A Armijo-Sánchez, N Benítez Castillo… - Clinical Medicine …, 2024 - journals.sagepub.com
Infertility affects 15% of couples in reproductive age worldwide. In women in particular,
infertility can be caused by various abnormalities, with polycystic ovary syndrome (PCOS) …

[HTML][HTML] Experience of treating patients with abnormal uterine bleeding associated with ovulatory dysfunction

GB Dikke, DA Novichkov… - Obstetrics and …, 2024 - journals.eco-vector.com
Abnormal uterine bleeding (AUB) associated with ovulatory disfunction (OD) is the most
common finding among women with chronic AUB, accounting for 57.7% of cases. Oral …

[HTML][HTML] Реабилитация пациенток после хирургического лечения синдрома поликистозных яичников

ОА Зайцева, АГ Cолопова - Реабилитология, 2024 - rehabilitology.com
Аннотация Одним из наиболее часто встречающихся гинекологических заболеваний
является синдром поликистозных яичников (СПКЯ). Патологические состояния, к …

Development of Research on the Etiology and Pathogenesis of Polycystic Ovary Syndrome

G Wei, M Wang, Y Yang, F He - Current Research in Medical …, 2023 - pioneerpublisher.com
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects 6-20% of
women of childbearing age (Zafar U, Memon Z, Moin K, et al, 2019). It usually manifests as …